OKYO PHARMA LTD SP.ADR/65 (OK10) — Net Asset Momentum
OKYO PHARMA LTD SP.ADR/65 (OK10) recorded a net asset momentum of 5.6% as of March 2025, with net assets of €-5.55 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check OKYO PHARMA LTD SP.ADR/65 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
OKYO PHARMA LTD SP.ADR/65 Net Asset Momentum (2022–2025)
This chart tracks OKYO PHARMA LTD SP.ADR/65's year-over-year net asset growth across 4 annual reporting periods from 2022 to 2025. The most recent momentum reading is +5.6%, with net assets of €-5.55 Million EUR as of March 2025. Read OK10 current and long-term liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for OKYO PHARMA LTD SP.ADR/65 (2022–2025)
The table below shows the complete annual net asset history for OKYO PHARMA LTD SP.ADR/65 from 2022 to 2025, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see market value of OKYO PHARMA LTD SP.ADR/65.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €-5.55 Million | €3.68 Million | €9.23 Million | ▲ +5.6% |
| 2024 | €-5.88 Million | €1.54 Million | €7.42 Million | ▼ -186.4% |
| 2023 | €-2.05 Million | €5.20 Million | €7.26 Million | ▼ -169.7% |
| 2022 | €2.95 Million | €4.30 Million | €1.35 Million | — |